Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |